PPARG and Alzheimer disease: By Days 7, 14, and 22, AD-ouab cells had lower PPARG levels (1.5-, 2.5-, and 2.4-fold, respectively, p<0.05) and lower LPL levels (25.4-, 7.2-, and 6.2-fold, respectively, p<0.008) compared to untreated AD cells.